Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0. The study details and page layout appear unchanged.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Revision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a versioning update to the documentation with no changes to the study details.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These changes affect only UI text and metadata and do not alter substantive study information, eligibility criteria, or results.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.3.4 added. Revision: v3.3.3 removed.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.